Skip to content

A comparative study of different surgical approaches for total knee replacement

A comparative study of different surgical approaches for total knee replacement

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039929
Enrollment
Unknown
Registered
2020-11-14
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Interventions

A:medial parapatellar (MP) approach
B:minimally invasive of medial parapatellar approach
C:quadriceps-sparing (QS) approach

Sponsors

The Third Hospital of Peking University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who underwent total knee arthroplasty for the first time before 2008; 2. Patients aged 50-80 years old, regardless of gender; 3. The patients who voluntarily participate in the clinical trial and sign the informed consent form have good compliance.

Exclusion criteria

Exclusion criteria: 1. Patients with acute trauma, tumor, severe osteoporosis and other immune diseases, severe contracture of muscles around hip / knee joint, etc.; 2. Patients with history of vascular and nerve injury, vasculitis, diabetic foot, etc.; 3. Patients with history of thrombosis in recent 3 months, such as pulmonary embolism, cerebral thrombosis, lower extremity deep venous thrombosis, etc.; 4. Patients with serious primary diseases such as cardio cerebrovascular disease, liver (ALT or ast > 2 times the upper limit of normal value), kidney (BUN > 1.5 times the upper limit of normal value, Cr > 1.5 times the upper limit of normal value), endocrine system, nervous system, hematopoietic system and disturbance of consciousness; 5. Pregnant or lactating patients; 6. Patients allergic to test drugs, human serum albumin allergy or severe allergic constitution, drug or alcohol dependence; 7. Patients who participated in other clinical trials in recent 3 months; 8. Other patients considered unsuitable by clinicians.

Design outcomes

Primary

MeasureTime frame
KSS score;knee range of motion;mechanical axis of the lower limb;lateral distal femoral angle;femoral flexion angle;medial proximal tibial angle;tibial slope;lateral patella displacement;lateral patella tilt;VAS Score;

Countries

China

Contacts

Public ContactJiakuo Yu

The Third Hospital of Peking University

yujiakuo@126.com+86 13331031448

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026